Newsroom

GHENT, Belgien--(BUSINESS WIRE)--Azalea Vision, ein belgisches Healthtech-Unternehmen, das die erste intelligente Kontaktlinse für medizinische Zwecke entwickelt, gab heute bekannt, dass es den ersten Patienten in seine NOA-Proof-of-Concept-Studie aufgenommen hat. Die Studie markiert den Beginn des klinischen Programms von Azalea, nachdem das Unternehmen für den Accelerator des Europäischen Innovationsrats (EIC) ausgewählt wurde. Die Studie wird bei Visser Contact Lenses (Niederlande) und am Un...

NEW YORK & SINGAPORE--(BUSINESS WIRE)--Alpaca receives in-principle approval from the Monetary Authority of Singapore for a Capital Markets Services license, advancing its global expansion....

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Eastern District of Virginia (Alexandria Division), captioned Hatweek v. Fluence Energy, Inc. , et al., Case No. 1:26-cv-08475, on behalf of persons and entities that purchased or otherwise acquired Fluence Energy, Inc. (“Fluence” or the “Company”) (NASDAQ: FLNC) securities between November 24, 2025 and September 16, 2026, in...

NEW YORK--(BUSINESS WIRE)--Enhanced Group Inc. (NYSE: ENHA) (“Enhanced” or the “Company”) today announced that its Board of Directors has approved a 1-for-10 reverse stock split of its Class A and Class B common stock (the “Reverse Stock Split”). The Board's action has been consented to by the holder of the majority of the Company's outstanding voting power, acting by written consent in lieu of a special meeting of shareholders. No further shareholder vote or action is required or being request...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), today broke ground on a $750 million expansion of its manufacturing facility in Hillsboro, Oregon, advancing plans announced in August to increase capacity for advanced drug delivery devices and to strengthen the company’s United States manufacturing capabilities. The event marks the start of construction for the 211,000-square-feet expansion, doubling the size of the existing site...

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 12 classes of mortgage-backed notes from OBX 2026-NQM15 Trust, a $758.7 million non-prime RMBS transaction. The underlying collateral, comprising 1,437 residential mortgages, with fixed-rate mortgages (FRMs) and hybrid adjustable-rate mortgages (ARMs) making up 93.6% and 6.4% of the pool, respectively. All of the loans are either classified as non-qualified mortgages (Non-QM; 45.7%) or exempt (54.3%) from the Ability-to-Repay/Qualif...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Orion Digital Corp. (NASDAQ: ORIO; TSX: ORIO) (“Orion Digital” or the “Company”) today announced that it received formal written confirmation from The Nasdaq Stock Market, LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq’s minimum bid price requirement. To regain compliance with the minimum bid price requirement, the Company’s shares of common stock were required to maintain a minimum closing bid price of US$1.00 or mor...

TORONTO & LOS ANGELES--(BUSINESS WIRE)--Sangoma Technologies Corporation (TSX: STC; NASDAQ: SANG) (“Sangoma”), a trusted industry leader uniquely offering businesses a choice of on-premises, cloud-based or hybrid communications solutions, and BRC Group Holdings, Inc. (NASDAQ: RILY) (“BRC”), a diversified holding company with a scaled business communications portfolio, announced today that the companies have entered into a definitive arrangement agreement (the “Arrangement Agreement”) pursuant t...

SAN FRANCISCO--(BUSINESS WIRE)--Anonymous Health, a healthcare technology company purpose-built for behavioral health, ABA therapy, and other healthcare providers, today announced that the Anonymous Health Platform has achieved HITRUST Essentials, 1-year (e1) Certification for cybersecurity and information protection.For healthcare providers, the certification provides an added level of assurance as AI and digital technology become more deeply integrated into how patients find, connect with, and...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (Nasdaq: SMMT) today announced key developments important to the company’s progress towards achieving its goal of making a significant difference in the lives of patients with cancer. Specifically, Summit has established agreements with AstraZeneca (LSE/STO/NYSE: AZN) for a strategic equity investment in Summit and a clinical collaboration focused on ivonescimab and sonesitatug vedotin (sone-ve). Moreover, Summit and AstraZeneca intend to evaluat...